Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - OTHER FINANCING ACTIVITIES
Other Financing Activities ALNY - Alnylam Pharmaceuticals, Inc.
172 M
LAST VALUE
-52.00%
2 YEAR CAGR
21.33%
5 YEAR CAGR
19.60%
10 YEAR CAGR